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Objectives. The purpose of this study was to determine the
precise incidence, therapeutic options and prognostic implica-
tions of electrical storm in patients with transvenous implantable
cardioverter-defibrillator (ICD) systems.
Background. Approximately 50% to 70% of patients treated
with an ICD receive appropriate device-based therapy within the
first 2 years. Most arrhythmic events require only one appropriate
ICD firing for termination. However, some patients receive mul-
tiple appropriate shocks during a short period of time, a condition
referred to as “arrhythmic or electrical storm.”
Methods. This prospectively designed observational study com-
prised 136 recipients of transvenous ICDs who were followed for
403 6 242 days. Electrical storm was defined as ventricular
tachycardia or fibrillation resulting in device intervention >23
times during a single 24-h period.
Results. During follow-up, 57/136 patients (42%) received ap-
propriate ICD therapy. Electrical storm occurred in 14/136 pa-
tients (10%) at an average of 133 6 135 days after ICD implan-
tation. The mean number of arrhythmic episodes constituting
electrical storm was 17 6 17 (range: 3 to 50; median 8) per
patient. In 12 patients, electrical storm required hospital admis-
sion. The arrhythmia cluster could be terminated by a combined
therapy with b-blockers and intravenous amiodarone whereas
class I antiarrhythmic drugs were only occasionally successful.
The cumulative probability of survival as estimated by the
Kaplan-Meier method showed that patients with an episode of
electrical storm did not have a worse outcome compared to those
without such an event.
Conclusions. Electrical storm represents a frequent event in
patients treated with modern ICDs. It occurs most commonly late
after ICD implantation and can be managed by combined therapy
with b-blockers and amiodarone. Electrical storm does not inde-
pendently confer increased mortality.
(J Am Coll Cardiol 1998;32:1909–15)
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Approximately 50% to 70% of patients treated with an im-
plantable cardioverter-defibrillator (ICD) receive appropriate
device-based therapy within the first 2 years following implan-
tation (1,2). In the majority of cases the total number of ICD
shocks remains limited and most arrhythmic events require
only one appropriate ICD firing for termination. However,
some patients receive multiple appropriate shocks during a
short period of time. This condition has been referred to as
“arrhythmic or electrical storm” (3,4). The precise definition of
this syndrome is still evolving, but a useful working definition
has recently been proposed in several studies evaluating the
efficacy of intravenous amiodarone in recurrent life-
threatening ventricular tachyarrhythmias (5,6). Electrical
storm was defined as recurrent ventricular tachycardia or
fibrillation occurring two or more times in a 24-h period, and
usually requiring electrical cardioversion or defibrillation (5,6).
At present, only a few studies have dealt with this clinical
syndrome in ICD recipients. An earlier study by Kim and
associates (7) suggested an approximately 20% incidence of
electrical storm, which occurred predominantly during the first
few days following implantation. In this study, the use of
epicardial patch electrodes with thoracotomy devices was
considered to be associated with greater electrical instability
compared to nonthoracotomy devices. More recently pub-
lished preliminary data have suggested an overall incidence of
approximately 10% to 30% incidence of electrical storm
among larger series of ICD patients (8–10). At present,
however, several important questions regarding this potentially
life-threatening syndrome have remained unanswered. For
instance, the precise time of occurrence of arrhythmia cluster-
ing after ICD implantation, appropriate clinical management
of these patients, and prognostic implications of electrical
storm are ill defined. Thus, the present prospective observa-
tional study aimed to answer these questions in a large cohort
of consecutive patients who had received contemporary trans-
venous ICDs in a single institution.
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Methods
Patient population. Consecutive patients with one or more
documented episodes of sustained ventricular tachycardia or
cardiac arrest due to ventricular fibrillation were considered
for the present analysis if they had received a transvenous ICD
system between July 1995 and January 1998 in our institution.
All but 17 patients underwent preoperative electrophysiologi-
cal testing using a standardized stimulation protocol with up to
three extrastimuli at two right ventricular sites. Patients rou-
tinely underwent predischarge device testing where no patient
failed to defibrillate successfully with the first discharge at a
safety margin of 10 Joules below maximum output. Patients
were followed for up to 935 days (mean 403 6 242 days) after
implantation at 2- to 3-month intervals. Details of subsequent
deterioration, clinical symptoms or death were recorded. At
each follow-up visit, the ICD was interrogated to obtain its
present programmed status and data on its operation.
ICD systems. All patients received multifunctional third-
or fourth-generation ICDs using a single transvenous lead in
116, an endocardial lead in conjunction with an additional
subcutaneous array electrode in 2, or an additional superior
vena cava electrode in 1 patient. A dual-chamber transvenous
ICD system was used in the remaining 17 patients. All im-
planted devices were capable of storing RR cycle lengths and
electrograms obtained from the endocardial leads except 20
Ventritex devices, which exclusively store electrograms. The
following ICD devices were implanted: CPI PRX 3: n 5 7; CPI
Mini 1741: n 5 1; CPI Mini: n 5 11; CPI Mini II: n 5 26; CPI
Mini AV: n 5 1; CPI Mini AVIIDR: n 5 6; CPI Mini III: n 5
3; Medtronic PCD 7220: n 5 8; Medtronic PCD 7221: n 5 25;
Medtronic PCD 7223: n 5 20; Medtronic PCD 7218C: n 5 1;
Medtronic PCD 7271 GEMDR: n 5 7; Ventritex Cadet: n 5
1; Ventritex Contour: n 5 11; Ventritex Contour MD: n 5 4;
Ventritex Angstrom: n 5 4.
Assessment of baroreflex sensitivity. Baroreflex sensitivity
(BRS) is a marker of the capability to reflexly increase vagal
activity and to decrease sympathetic activity in response to a
sudden increase in blood pressure (11). In the present study,
BRS was determined at the time of ICD implantation using the
phenylephrine method devised by Smyth and co-workers (12).
This method uses the intravenous (IV) injection of small doses
of phenylephrine to increase arterial pressure. Changes in
blood pressure and heart rate are recorded on a beat-by-beat
basis and plotted against each other. The slope of this regres-
sion line (expressed as msec of increase in RR interval per mm
Hg rise in pressure) allows quantification of the sensitivity of
arterial baroreflex control of heart rate. Three consecutive
measurements were performed, and the corresponding slopes
were averaged to reduce measurement variability.
Definition of electrical storm. Because no generally ac-
cepted definition of electrical storm exists, this event was
defined for the purpose of this analysis as the occurrence of
ventricular tachycardia or fibrillation resulting in device inter-
vention (antitachycardia pacing and/or shock delivery) three or
more times within a 24-h period. For each arrhythmia episode,
the appropriateness of ICD therapy was verified by device
interrogation as described above.
Statistical analysis. All data were prospectively entered in
a customized data base and subsequently analyzed using
Statistical package for the Social Sciences (13). Measures are
reported as mean 6 SD. Patient characteristics were compared
across the three patient groups using a Mantel-Haenszel test
for categorical variables and analysis of variance for continu-
ous variables. Individual groups were then compared using the
Scheffe test (14). The cumulative probability of survival was
determined by the Kaplan-Meier method (15), and differences
in survival between groups were evaluated with the log-rank
test (16). A p value of ,0.05 was considered statistically
significant.
Results
Patient characteristics. This study is based on analysis of
data from 136 consecutive patients previously resuscitated
from cardiac arrest or with a history of sustained ventricular
tachycardia who subsequently were treated with a multifunc-
tional transvenous ICD system at our institution (Table 1).
There were 110 men and 26 women with a mean age of 61 6
14 years (range 23 to 79 years). The majority of patients
suffered from coronary artery disease or from idiopathic
dilated cardiomyopathy. Left ventricular ejection fraction
averaged 36 6 14% (range 15 to 74%). Thirty-seven percent of
patients had a history of ventricular fibrillation and 53% of
ventricular tachycardia. Both ventricular fibrillation and tachy-
cardia had been previously documented in the remaining 13
patients (10%). There was no perioperative mortality among
these patients.
During follow-up (403 6 242 days), 57 patients (42%)
received at least one appropriate ICD therapy. The time from
Table 1. Clinical Characteristics of 136 Consecutive ICD Recipients
Age (yrs) 61 6 14 (range: 23–79)
Gender
Males (%) 110 (81%)
Females (%) 26 (19%)
Underlying heart disease
Coronary artery disease 94 (69%)
Idiopathic dilated cardiomyopathy 29 (21%)
Hypertrophic cardiomyopathy 5 (4%)
Aortic valve replacement 3 (2%)
None 5 (4%)
Left ventricular ejection fraction (%) 36 6 14 (range: 13–74)
Presenting arrhythmia
Ventricular fibrillation 51 (37%)
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implantation to the first device therapy averaged 124 6 145
days.
Electrical storm. Fourteen of 136 consecutive patients
(10%) (Table 2) experienced an episode of electrical storm
during follow-up. This arrhythmia clustering occurred at an
average of 133 6 135 days after ICD implantation. Following
the first electrical storm episode, three patients subsequently
presented with a second episode. Table 3 shows the compari-
son of clinical characteristics of patients with and without
episodes of electrical storm. Except the difference in age, this
analysis did not reveal any other significant difference.
Careful analysis of ICD-stored electrograms demonstrated
that electrical storm consisted of the occurrence of repeated
episodes of ventricular tachycardia in 10 and ventricular fibril-



















1 m 63 DCM VF 30 109 13 3 VF syncope yes
2 f 68 CAD VT/VF 25 75 9 3 VF presyncope yes
3 m 70 CAD VT/VF 37 42 3 3 VT minor symptoms no
4 f 57 CAD VT 60 1 4 3 VT minor symptoms yes
5 m 76 CAD VT 25 1 6 3 VT minor symptoms yes
6 m 68 CAD VT/VF 38 56 32 3 VT presyncope yes
7 m 71 CAD VT 45 128 48 3 VT presyncope yes
8 m 72 CAD VT 33 35 3 3 VT none no
9 f 63 CAD VT 30 150 50 3 VT presyncope yes
163 16 3 VT minor symptoms yes
10 m 74 CAD VF 40 339 6 3 VT presyncope yes
11 m 58 CAD VT 30 200 18 3 VT presyncope no
250 17 3 VT/VF syncope yes
12 m 57 CAD VT 55 1 3 3 VF presyncope yes
13 m 68 DCM VF 25 330 43 3 VT presyncope yes
14 m 52 CAD VT 35 371 6 3 VF syncope yes
480 4 3 VT/VF presyncope yes
CAD 5 coronary artery disease; DCM 5 dilated cardiomyopathy; LVET 5 left ventricular ejection fraction; VF 5 ventricular fibrillation; VT 5 ventricular
tachycardia; 3 5 times.








or Shock p Value
Patients 14 43 79 —
Age (yrs) 65 6 7 60 6 11 61 6 11 NS
Gender
Males (%) 11 (78%) 34 (79%) 65 (82%) NS
Females (%) 3 (22%) 9 (21%) 14 (18%)
Underlying heart disease
CAD 12 (86%) 26 (60%) 56 (71%) NS
IDC 2 (14%) 12 (28%) 15 (19%)
HCM — 1 (3%) 4 (5%)
Other — 2 (5%) 1 (1%)
None — 2 (5%) 3 (4%)
LVEF (%) 37 6 11 (25–60) 33 6 12 (13–65) 36 6 14 (15–74) NS
Presenting arrhythmia
Ventricular fibrillation 3 (21%) 17 (40%) 31 (39%) NS
Ventricular tachycardia 8 (57%) 24 (55%) 40 (51%)
Both 3 (21%) 2 (5%) 8 (10%)
Concomitant drug therapy
Digoxin 3 (21%) 5 (12%) 8 (10%)
Diuretics 2 (14%) 4 (9%) 16 (20%) NS
Amiodarone — 1 (3%) 1 (1%)
b-blocker 12 (86%) 31 (72%) 61 (77%)
CAD 5 coronary artery disease; IDC 5 idiopathic dilated cardiomyopathy; HCM 5 hypertrophic cardiomyopathy; ATP 5 antitachycardia pacing.
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lation in 4 patients. The mean number of arrhythmic episodes
constituting electrical storm was 17 6 17 (range: 3 to 50;
median 8) per patient. The ICD interrogation revealed no
evidence for device malfunctioning or inappropriate shock
delivery for supraventricular arrhythmias. Ten patients experi-
enced syncope or presyncope during the event, whereas no
hemodynamic compromise was apparent in four patients.
Three patients had minor symptoms such as palpitations or
light-headedness.
In seven patients, electrical storm represented the first
arrhythmic episode resulting in appropriate ICD therapy after
implantation. Seven patients had had prior episodes of ven-
tricular tachyarrhythmias terminated by their ICD before they
developed electrical storm.
Precipitating factors for electrical storm could be identified
in only five patients (26%). Hypokalemia (serum potassium
#3.5 mmol/l) was present in three patients. Another patient
developed acute myocardial ischemia resulting in subsequent
recurrent myocardial infarction 2 days after cessation of elec-
trical storm. One patient developed acute congestive heart
failure and was treated with IV diuretics at which time he
developed electrical storm despite normal serum potassium
levels. In the remaining patients, careful analysis of symptoms,
electrocardiograms (ECGs), and laboratory values revealed no
apparent triggering factors for the electrical storm.
Electrical storm and vagal reflex activity. The BRS was
assessed in 105/136 patients; BRS could not be assessed due to
atrial fibrillation in 15 patients and to pacemaker dependence
in 7 patients. In five patients, BRS could not be analyzed owing
to technical problems, whereas four patients declined to
undergo BRS assessment. The BRS averaged 4.5 6
5.0 msec/mm Hg for the total patient cohort and was signifi-
cantly different across the three patient groups (p 5 0.05).
Patients without ICD interventions during follow-up had a
better preserved BRS (5.4 6 6.1 msec/mm Hg) than did
patients with appropriate ICD therapy (3.1 6 2.4 msec/mm
Hg; p 5 0.08). Patients with electrical storm had a similarly
depressed BRS of 3.1 6 2.2 msec/mm Hg; owing to the smaller
number of patients in this group, however, this difference did
not reach the level of statistical significance.
Management of electrical storm. Nine of 12 patients with
electrical storm requiring in-hospital pharmacological therapy
were treated in our institution according to a prespecified
therapeutic regimen. Antiadrenergic therapy by means of
intensifying or starting b-blocker treatment was commenced by
IV administration of 2.5 to 10 mg metoprolol. This was
followed by IV administration of a class I antiarrhythmic
substance (ajmaline 0.5 to 1.0 mg/kg). When electrical storm
did not subside following these therapeutic measures, IV
administration of amiodarone was initiated (bolus infusion of
300 mg for 1 h followed by 1.2 g/24 h). Whereas the combined
therapy with b-blocker and the class I drug terminated the
arrhythmia cluster in only three patients, all other patients
could be stabilized during the infusion of amiodarone. Except
in two patients, this averaged 10 6 9 h (range 1 to 24 h; median
3.5 h). In the remaining two patients, amiodarone infusion had
to be continued for 133 and 432 h, respectively, until no further
breakthrough arrhythmia was observed. All of these patients
continued to receive oral therapy with amiodarone at the time
of hospital discharge.
Two patients without hemodynamic compromise or only
minor symptoms during their arrhythmia cluster did not con-
sult a physician; accordingly, their arrhythmic episodes and
consecutive ICD interventions were only detected on the next
regular follow-up visit in the outpatient clinic. Because electri-
cal storm had subsided at the time of their presentation, no
changes in concomitant therapy were deemed necessary.
Prognostic implications of electrical storm. Patients with
electrical storm were followed in the arrhythmia outpatient
clinic for the remaining observation period of 306 6 215 days
(range: 38 to 626 days) after cessation of the arrhythmia
cluster. Two patients had to be hospitalized again for another
episode of electrical storm 13 and 115 days after their first
event, respectively. Eventually, both cases could be managed
successfully. Two patients with a previous episode of electrical
storm died 257 and 182 days after cessation of electrical storm
due to progressive heart failure. In the group of patients with
only single appropriate ICD interventions (n 5 43; follow-up
500 6 245 days), two patients died of progressive heart failure
and one died of cancer. There were three deaths, all due to
progressive heart failure, in the group of patients without any
ICD intervention during an average follow-up of 352 6 234
days. Figure 1 shows the cumulative probability of survival of
these three patient groups from the time of ICD implantation.
As demonstrated, there was no significant difference in survival
for patients with electrical storm compared to those without
electrical storm during their clinical course.
Discussion
Main findings. The present study reveals several new
findings. It demonstrates that a substantial proportion of
patients treated with modern ICD devices experience at least
one episode of multiple adequate ICD therapies during a
single 24-h period. In this series, 14/136 patients (10%) showed
such an episode of electrical storm. These 14 patients repre-
sent one-fourth of all patients who received at least one
appropriate ICD therapy during follow-up. Electrical storm
required in-hospital therapy in 12/14 patients (86%), thus
significantly impacting on ICD-related treatment costs. How-
ever, extended follow-up of these patients demonstrated that
electrical storm does not independently confer increased mor-
tality.
Definition of electrical storm. At present, there is no
commonly agreed definition of electrical storm. It represents a
serious but treatable clinical syndrome of recurrent severe
ventricular arrhythmias most commonly observed in patients
with advanced structural heart disease. A useful working
definition has been recently proposed in two prospective
studies (5,6) where electrical storm was defined as recurrent
ventricular tachycardia or ventricular fibrillation occurring
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more than two times in a 24-h period. Moreover, it usually
requires electrical cardioversion or defibrillation (5,6).
This entity should be differentiated from so-called incessant
ventricular tachycardia. Although there has been no consis-
tency in the definition of this term as well, incessant ventricular
tachycardia implies that a patient is in monomorphic ven-
tricular tachycardia for a significant portion of the day. For
instance, Lemery et al. (17) have defined it as the presence of
ventricular tachycardia for at least one half of each of 3 days
during a continuous observation period. A similar definition
implying the presence of sustained and nonsustained tachycar-
dia resulting in total ventricular ectopic beats in 24 h more than
total sinus beats has been used by Hariman and associates (18).
Incidence and time of occurrence of electrical storm.
There is only sparse data in the literature concerning the
incidence of electrical storm in ICD populations as defined in
the present study. Most of these data stem from patient
samples evaluated in the late 1980s or early 1990s, implying
that most of these patients had been treated with thoracotomy
ICD devices. For instance, O’Donoghue and co-workers (9)
reported on 130 ICD recipients of whom 12 (9%) showed at
least one episode of electrical storm defined as 10 or more
appropriate ICD discharges during a 48-h period. More re-
cently, a preliminary report (10) demonstrated an incidence of
23% (35/149 patients) of cases of electrical storm; although not
specified in the paper, it can be assumed that many of those
patients had received modern nonthoracotomy ICD devices.
These numbers are in excellent agreement with the present
finding of a 10% incidence of electrical storm in patients
exclusively treated with modern nonthoracotomy ICDs.
Another important question relates to the precise time of
occurrence of electrical storm after ICD implantation. In the
beginning of widespread ICD therapy, most episodes of in-
creased electrical instability were reported to occur in the
immediate postoperative period (7). For instance, Kim and
associates (7) observed 9/52 patients who developed recurrent
ventricular tachycardias requiring intervention during the im-
mediate postoperative phase after implantation of thora-
cotomy ICDs. The same authors noted postoperative unstable
ventricular tachycardia in 4/59 recipients of a nonthoracotomy
device. Accordingly, these authors concluded that an exacer-
bation of ventricular arrhythmia is common during the imme-
diate postoperative phase, particularly in patients undergoing
thoracotomy for placement of epicardial patch electrodes.
Unfortunately, there is a lack of data concerning the occur-
rence of electrical storm during follow-up in such patients.
The present observations indicate that by far the majority of
electrical storm episodes occur late after ICD implantation. In
fact, of the 14 episodes, only 3 were noted during the first 48 h
after surgery. In the remaining 11 patients, electrical storm
occurred on average 169 6 130 days after ICD placement. This
figure is in accordance with the preliminary data provided by
Greene et al. (10), who reported an average of 259 6 353 days
for their patient population. These findings clearly indicate
that electrical storm in recipients of modern nonthoracotomy
ICD devices is not related to surgical factors such as mechan-
ical irritation or inflammatory processes. Moreover, the fact
that electrical storm represented the first episode of appropri-
ate ICD therapy delivery in 7/57 cases (12%) in this series
indicates that electrical storm reflects an episode of enhanced
electrical instability that can occur at any time in individuals
with a history of life-threatening ventricular tachyarrhythmias.
Precipitating factors for electrical storm. A number of
well-known precipitating factors significantly increase the
electrical instability of the heart. Among them, myocardial
ischemia is probably one of the most important factors. In this
series, there was one patient in whom myocardial ischemia was
proven to be the trigger for electrical instability. This patient
eventually developed recurrent myocardial infarction several
days following the cessation of electrical storm and died of
extensive left ventricular damage as a result. Other triggering
factors include the development of electrolyte disturbances
such as profound hypokalemia, which was demonstrated in
three of our patients. Finally, episodes of acute congestive
heart failure with resulting increase in sympathetic tone may
give rise to enhanced electrical instability upon which drug
Figure 1. Cumulative probability of survival in pa-
tients with electrical storm, without electrical storm
but ICD interventions for single arrhythmia events,
and in patients without any ICD intervention during
follow-up.
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treatment for congestive heart failure often acts to further
increase electrolyte disturbances. Proarrhythmic side effects of
antiarrhythmic drugs may also constitute a precipitating factor
for recurrent ventricular tachycardia or fibrillation.
Our results also provide new data on the role of the
autonomic nervous system in the genesis of electrical storm.
Several previous reports have demonstrated that vagal reflex
activity is depressed in patients with life-threatening ventricu-
lar arrhythmias (19–21). The present study demonstrates for
the first time a diminished BRS in patients with compared to
those without appropriate ICD interventions during follow-up.
This result extends previous findings (19–21) and further
corroborates the decisive role of the autonomic nervous system
in the genesis of sudden cardiac death (22). The second
important aspect of our analysis of BRS is that patients with
electrical storm do not differ in terms of their capability to
reflexly increase vagal activity from individuals with only single
ICD interventions. Thus, it is intriguing to speculate that
further impairment in the ability to activate vagal reflexes
appears not to be a prerequisite for triggering electrical storm
in ICD recipients.
Prognostic implications of electrical storm. One of the
most important aspects of the current study relates to potential
prognostic implications of electrical storm. At present, there is
a paucity of information on this clinically important issue. A
recent report of Villacastin and co-workers (23) on 80 ICD
recipients indicated that multiple consecutive high-energy ICD
discharges were an independent predictor of subsequent car-
diac and arrhythmic mortality. On first glance, this appears to
be in contrast to our findings, which demonstrate that outcome
of patients with multiple discharges was similar to that of
individuals with only single appropriate ICD discharges or no
ICD therapy at all during follow-up. There are two explana-
tions for this apparent discrepancy. In the study of Villacastin
et al. (23), patients with electrical storm had a significantly
worse left ventricular function (LVEF 26 6 4%) compared to
patients with single appropriate ICD discharges (39 6 3%) or
no ICD therapy (43 6 2%). Because the degree of left
ventricular dysfunction is the most important single prognostic
factor in all patients with a history of life-threatening ventric-
ular arrhythmias (24–26), occurrence of electrical storm in the
study of Villacastin et al. (23) may be considered an epiphe-
nomen of the impairment of LVEF.
In contrast, in the present study there was no significant
difference in the degree of left ventricular dysfunction in
patients with or without electrical storm. Accordingly, the
subsequent clinical course of these patients was similar. The
second explanation is related to the fact that in the study of
Villacastin et al. (23), another definition for electrical storm
was used; these investigators examined the prognostic value of
repeated ICD shocks delivered for termination of one arrhyth-
mia episode, unlike in our study where the occurrence of
multiple arrhythmia episodes within a single 24-h time period
was evaluated. Moreover, our findings are supported by pre-
liminary data of Greene and co-workers (10), which also failed
to demonstrate prognostic implications of electrical storm.
Acute management of electrical storm. The majority of
patients with electrical storm in this series who were in the
need of in-hospital treatment were admitted to the same
institution and were managed by adhering to a prospectively
defined therapeutic regimen. This fact allows some comments
on acute handling of such patients despite the uncontrolled
and nonrandomized nature of antiarrhythmic drug therapy. In
all patients, attention was paid to correct potential trigger
factors such as electrolyte disturbances before specific antiar-
rhythmic drug therapy was instituted. According to the hypoth-
esis that myocardial ischemia and an increase in sympathetic
tone may be major precipitating factors, therapy with
b-adrenergic blocking substances was initiated or intensified
whenever possible. The importance of antiadrenergic therapy
has recently been illustrated in a patient who had 76 appropri-
ate ICD shocks for recurrent ventricular fibrillation and could
be successfully managed by IV metoprolol (4). Nademanee
and Singh reported a similar experience some years ago (27).
Finally, when specific antiarrhythmic drug therapy was
necessary due to recurrence of arrhythmic episodes (mean
number of events constituting electrical storm was 17 6 17), IV
administration of amiodarone was initiated. Utilizing this drug
regimen, the majority of patients could be stabilized within a
relatively short period of time (median 3.5 h). This experience
is in agreement with recent reports on the utility of IV
amiodarone in the treatment of recurrent life-threatening
ventricular arrhythmias (5,6,28). Furthermore, amiodarone is
not only effective in suppressing recurrent ventricular tachy-
cardia or fibrillation but also carries a low proarrhythmic
potential (29).
Conclusions. Electrical storm occurs frequently in ICD
recipients even when contemporary nonthoracotomy devices
are used. In many instances, electrical storm represents the
first arrhythmic event after ICD implantation resulting in
appropriate device therapy. The capability to reflexly increase
vagal tone is diminished both in patients with single ICD
interventions and with electrical storm to a similar extent. In
patients with frequent ICD shocks, IV amiodarone therapy is
effective in suppressing further arrhythmic episodes. As indi-
cated by the results of this study, electrical storm is not
necessarily a harbinger of poor prognosis in these patients.
The authors wish to express their gratitude to H. Ackermann, PhD, Department
of Biostatistics, J.W. Goethe University, Frankfurt, for his expertise in helping to
perform the statistical analysis of this data.
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